Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585675 · ClinicalTrials.gov registry record
Specimen Banking From Patients With Lung Cancer
A clinical trial of Lung Neoplasms, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01585675: Recruiting study of Lung Neoplasms, sponsored by University of Colorado, Denver.
NCT01585675 is a study of Lung Neoplasms that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 2,000 participants, above the 376-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (432% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01585675, a study of Lung Neoplasms, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
Primary Outcome
No statistical analysis will be applied to the overall collection of samples. Rather, each project that utilized tissue bank resources will require an appropriate statistical plan to be submitted along with the initial tissue request.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Cancer Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2005-11-03 |
| Est. Completion | 2035-07-01 |
What NCT01585675 shows while recruiting
NCT01585675 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 376-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (432% higher).
The record links to 1 condition, with Lung Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT01585675 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01585675 about?
NCT01585675 is a clinical study titled "Specimen Banking From Patients With Lung Cancer". The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
What is the current status of trial NCT01585675?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2005-11-03. Estimated completion is 2035-07-01.
What conditions does trial NCT01585675 study?
This clinical trial studies the following conditions: Lung Neoplasms.
Who is sponsoring clinical trial NCT01585675?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01585675 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01585675's enrollment target sits among peer trials
2,000 2nd of 22 the highest of 22 other Lung Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
TELESCOPE- TELEhealth Shared Decision-making COaching
RECRUITING · NA
-
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
RECRUITING · NA
-
Circulating Tumor Cells (CTC) in Lung Cancer
RECRUITING
-
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI